Frances Arnold
Frances Arnold’s work has been recognised by many awards including the 2018 Nobel Prize in Chemistry for pioneering the use of directed evolution to engineer enzymes. Arnold is co-inventor on over 40 US patents. Throughout her esteemed career and many achievements, Frances Arnold co-founded Gevo, Inc a company to make fuels and chemicals from renewable resources in 2005. She has been on the corporate board of the genomics company Illumina Inc since 2016 and in 2019, she was named to the board of Alphabet Inc., making Arnold the third female director of the Google parent company.
At Caltech, Arnold runs a laboratory that continues to study directed evolution and its applications in environmentally friendly chemical synthesis and green/alternative energy, including the development of highly active enzymes (cellulolytic and biosynthetic enzymes) and microorganisms to convert renewable biomass to fuels and chemicals.
Dr. Heather Jones
Dr. Jones is a pulmonary-critical care medicine specialist and physician-researcher with more than 20 years’ experience practicing medicine and conducting basic, translational and clinical research.
Dr. Jones leads Armata’s clinical development efforts with the goal of advancing its natural and synthetic phage product candidates through randomized controlled trials, supporting a path to registration. Dr. Jones continues to spend a small percentage of her time practicing critical care medicine, which allows her to remain connected to patients with life-threatening infections whom Armata is committed to helping with phage therapy.
Previously, Dr. Jones served as Director of the Lung Imaging Program, Biomedical Imaging Research Institute, and Attending physician in the medical intensive care unit at Cedars-Sinai Medical Center in Los Angeles. Her academic appointments included Associate Professor of Medicine and Biomedical Sciences at Cedars-Sinai, as well as Health Sciences Associate Clinical Professor at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Jones’s prior research focused on acute lung injury and novel lung imaging techniques. Dr. Jones has authored numerous peer-reviewed publications, delivered numerous invited presentations and received private and government grants including KL2 and K08 grants from the National Institutes of Health.
Dr. Jones earned her BA in Molecular and Cell Biology with Honors from the University of California, Berkley and a Doctor of Medicine, Magna Cum Laude, from the Medical College of Pennsylvania/Hahnemann University (now Drexel Medical School). Dr. Jones completed her residency in Internal Medicine at Boston Medical Center and her pulmonary and critical care fellowship training at Johns Hopkins Hospital, followed by an extended research fellowship at the Pulmonary Branch of the National Heart, Lung and Blood Institute.